About

Investors Overview

Home > Investor Relations > Investors Overview
Webcast ImageWebcast
Q1 2013 Bacterin International Holdings Inc Earnings Conference Call (Replay)
05/10/13 at 10:00 a.m. ET
Q1 2013 Bacterin International Holdings Inc Earnings Conference Call
Friday, May 10, 2013 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (NYSE: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in spi... More >>

Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.
 
Stock Quote
BONE (Common Stock)
ExchangeNYSE (US Dollar)
Price$0.68
Change (%) Stock is Down 0.06 (8.11%)
Volume168,206
Data as of 05/24/13 3:58 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
05/16/13Bacterin Receives Compliance Notice from NYSE MKT
BELGRADE, Mont.--(BUSINESS WIRE)--May. 16, 2013-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it has received a compliance notice from the NYSE MKT compliance group. Specifically the notice indicated that the Company is not in compliance with Sections 1003(a)(iii) and 1003(a)(ii), regarding stockholder’s ... 
Printer Friendly Version
05/09/13Bacterin Announces First Quarter 2013 Revenue of $8.6 Million
First Quarter 2013 Highlights: Revenue increased 11% year over year, to approximately $8.6 million, and increased 6% over reported revenues for the fourth quarter of 2012 Loss from operations decreased 3% compared to the first quarter of 2012, to approximately $(1.2) million, and decreased 65% compared to the loss from operations in the fourth quarter of 2012 BELGRADE, Mont.--(BUSINESS WIRE)--... 
Printer Friendly Version
04/30/13Bacterin Announces Earnings Release and Conference Call Date for 2013 First Quarter Results
BELGRADE, Mont.--(BUSINESS WIRE)--Apr. 30, 2013-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it will release its financial results for the period ended March 31, 2013, on May 9, 2013 at the close of the financial markets. An accompanying conference call hosted by John Gandolfo, Chief Financial Officer an... 
Printer Friendly Version
04/26/13Bacterin Announces Selection of Executive Search Firm
BELGRADE, Mont.--(BUSINESS WIRE)--Apr. 26, 2013-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced the selection of O’Hara Associates, Inc. of Deerfield, Illinois to assist in the recruitment of a Chief Executive Officer. The recommendation to retain the firm was made by the Board’s Nominations and Corporate Govern... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
What's New
There are currently no items available.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.